CLASSIFICATION OF MULTIPLE CANCER TYPES USING FUZZY SUPPORT VECTOR MACHINES AND OUTLIER DETECTION METHODS

2005 ◽  
Vol 17 (06) ◽  
pp. 300-308 ◽  
Author(s):  
LI-YEH CHUANG ◽  
CHENG-HONG YANG ◽  
LI-CHENG JIN
Keyword(s):  
Support Vector Machine ◽  
Outlier Detection ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Detection Methods ◽  
Support Vector ◽  
Fuzzy Support Vector Machine ◽  
Multiple Cancer ◽  
Flexible Architecture ◽  
Cancer Types

The support vector machine (SVM) is a new learning method and has shown comparable or better results than the neural networks on some applications. In this paper, we applied SVM to classify multiple cancer types by gene expression profiles and exploit some strategies of the SVM method, including fuzzy logic and statistical theories. Using the proposed strategies and outlier detection methods, the FSVM (fuzzy support vector machine) can achieve a comparable or better performance than other methods, and provide a more flexible architecture to discriminate against SRBCT and non-SRBCT samples.

scholarly journals Convolutional neural network for human cancer types prediction by integrating protein interaction networks and omics data

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yi-Hsuan Chuang ◽  
Sing-Han Huang ◽  
Tzu-Mao Hung ◽  
Xiang-Yu Lin ◽  
Jung-Yu Lee ◽  
...  
Keyword(s):  
Neural Network ◽  
Gene Expression ◽  
Cancer Diagnosis ◽  
Protein Interaction ◽  
Human Cancer ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Multiple Cancer ◽  
Diagnosis And Prognosis ◽  
Cancer Types

AbstractMany studies have proven the power of gene expression profile in cancer identification, however, the explosive growth of genomics data increasing needs of tools for cancer diagnosis and prognosis in high accuracy and short times. Here, we collected 6136 human samples from 11 cancer types, and integrated their gene expression profiles and protein–protein interaction (PPI) network to generate 2D images with spectral clustering method. To predict normal samples and 11 cancer tumor types, the images of these 6136 human cancer network were separated into training and validation dataset to develop convolutional neural network (CNN). Our model showed 97.4% and 95.4% accuracies in identification of normal versus tumors and 11 cancer types, respectively. We also provided the results that tumors located in neighboring tissues or in the same cell types, would induce machine make error classification due to the similar gene expression profiles. Furthermore, we observed some patients may exhibit better prognosis if their tumors often misjudged into normal samples. As far as we know, we are the first to generate thousands of cancer networks to predict and classify multiple cancer types with CNN architecture. We believe that our model not only can be applied to cancer diagnosis and prognosis, but also promote the discovery of multiple cancer biomarkers.

Predicting Hub Genes of Glioblastomas Based on Support Vector Machine Combined with CFS algorithms

2020 ◽  
Vol 15 ◽  
Author(s):  
Chun Qiu ◽  
Sai Li ◽  
Shenghui Yang ◽  
Lin Wang ◽  
Aihui Zeng ◽  
...  
Keyword(s):  
Support Vector Machine ◽  
Expression Profiles ◽  
Independent Set ◽  
Classification Model ◽  
Support Vector ◽  
Feature Subset ◽  
Hub Genes ◽  
Effective Prevention ◽  
Key Genes ◽  
Control Samples

Aim: To search the genes related to the mechanisms of the occurrence of glioma and to try to build a prediction model for glioblastomas. Background: The morbidity and mortality of glioblastomas are very high, which seriously endangers human health. At present, the goals of many investigations on gliomas are mainly to understand the cause and mechanism of these tumors at the molecular level and to explore clinical diagnosis and treatment methods. However, there is no effective early diagnosis method for this disease, and there are no effective prevention, diagnosis or treatment measures. Methods: First, the gene expression profiles derived from GEO were downloaded. Then, differentially expressed genes (DEGs) in the disease samples and the control samples were identified. After that, GO and KEGG enrichment analyses of DEGs were performed by DAVID. Furthermore, the correlation-based feature subset (CFS) method was applied to the selection of key DEGs. In addition, the classification model between the glioblastoma samples and the controls was built by an Support Vector Machine (SVM) based on selected key genes. Results and Discussion: Thirty-six DEGs, including 17 upregulated and 19 downregulated genes, were selected as the feature genes to build the classification model between the glioma samples and the control samples by the CFS method. The accuracy of the classification model by using a 10-fold cross-validation test and independent set test was 76.25% and 70.3%, respectively. In addition, PPP2R2B and CYBB can also be found in the top 5 hub genes screened by the protein– protein interaction (PPI) network. Conclusions: This study indicated that the CFS method is a useful tool to identify key genes in glioblastomas. In addition, we also predicted that genes such as PPP2R2B and CYBB might be potential biomarkers for the diagnosis of glioblastomas.

Detection of Dendritic Spines Using Wavelet Packet Entropy and Fuzzy Support Vector Machine

2017 ◽  
Vol 16 (2) ◽  
pp. 116-121 ◽  
Author(s):  
Shuihua Wang ◽  
Yang Li ◽  
Ying Shao ◽  
Carlo Cattani ◽  
Yudong Zhang ◽  
...  
Keyword(s):  
Support Vector Machine ◽  
Dendritic Spines ◽  
Wavelet Packet ◽  
Support Vector ◽  
Fuzzy Support Vector Machine

scholarly journals Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

2021 ◽  
Vol 14 (1) ◽  
pp. 41
Author(s):  
Hana Votavova ◽  
Zuzana Urbanova ◽  
David Kundrat ◽  
Michaela Dostalova Merkerova ◽  
Martin Vostry ◽  
...  
Keyword(s):  
Gene Expression ◽  
Immune Response ◽  
Blood Cell ◽  
Myelodysplastic Syndrome ◽  
Molecular Mechanisms ◽  
Expression Profiles ◽  
Adaptive Immune Response ◽  
Gene Expression Profiles ◽  
Iron Chelator ◽  
Multiple Cancer

Deferasirox (DFX) is an oral iron chelator used to reduce iron overload (IO) caused by frequent blood cell transfusions in anemic myelodysplastic syndrome (MDS) patients. To study the molecular mechanisms by which DFX improves outcome in MDS, we analyzed the global gene expression in untreated MDS patients and those who were given DFX treatment. The gene expression profiles of bone marrow CD34+ cells were assessed by whole-genome microarrays. Initially, differentially expressed genes (DEGs) were determined between patients with normal ferritin levels and those with IO to address the effect of excessive iron on cellular pathways. These DEGs were annotated to Gene Ontology terms associated with cell cycle, apoptosis, adaptive immune response and protein folding and were enriched in cancer-related pathways. The deregulation of multiple cancer pathways in iron-overloaded patients suggests that IO is a cofactor favoring the progression of MDS. The DEGs between patients with IO and those treated with DFX were involved predominantly in biological processes related to the immune response and inflammation. These data indicate DFX modulates the immune response mainly via neutrophil-related genes. Suppression of negative regulators of blood cell differentiation essential for cell maturation and upregulation of heme metabolism observed in DFX-treated patients may contribute to the hematopoietic improvement.

Sign in / Sign up

Export Citation Format

Share Document